| Literature DB >> 26106527 |
Devasuda Anblagan1, Mark E Bastin2, Sarah Sparrow3, Chinthika Piyasena4, Rozalia Pataky3, Emma J Moore3, Ahmed Serag3, Alastair Graham Wilkinson5, Jonathan D Clayden6, Scott I Semple7, James P Boardman1.
Abstract
Preterm birth is associated with altered connectivity of neural circuits. We developed a tract segmentation method that provides measures of tract shape and integrity (probabilistic neighborhood tractography, PNT) from diffusion MRI (dMRI) data to test the hypotheses: 1) preterm birth is associated with alterations in tract topology (R), and tract-averaged mean diffusivity (〈D〉) and fractional anisotropy (FA); 2) neural systems are separable based on tract-averaged dMRI parameters; and 3) PNT can detect neuroprotective treatment effects. dMRI data were collected from 87 preterm infants (mean gestational age 29(+1) weeks, range 23(+2) -34(+6)) at term equivalent age and 24 controls (mean gestational age 39(+6) weeks). PNT was used to segment eight major fasciculi, characterize topology, and extract tract-averaged〈D〉and FA. Tract topology was altered by preterm birth in all tracts except the splenium (p < 0.05, false discovery rate [FDR] corrected). After adjustment for age at scan, tract-averaged〈D〉was increased in the genu and splenium, right corticospinal tract (CST) and the left and right inferior longitudinal fasciculi (ILF) in preterm infants compared with controls (p < 0.05, FDR), while tract-averaged FA was decreased in the splenium and left ILF (p < 0.05, FDR). Specific fasciculi were separable based on tract-averaged〈D〉and FA values. There was a modest decrease in tract-averaged〈D〉in the splenium of preterm infants who had been exposed to antenatal MgSO4 for neuroprotection (p = 0.002). Tract topology is a biomarker of preterm brain injury. The data provide proof of concept that tract-averaged dMRI parameters have utility for evaluating tissue effects of perinatal neuroprotective strategies.Entities:
Keywords: Brain; Infant; Magnesium sulfate; Magnetic resonance image; Neuroprotection; Preterm
Mesh:
Substances:
Year: 2015 PMID: 26106527 PMCID: PMC4473726 DOI: 10.1016/j.nicl.2015.03.021
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Demographic information for the participants.
| Preterm at term equivalent age ( | Controls ( | |
|---|---|---|
| PMA birth/weeks (mean and range) | 29+1 (23+2 –34+6) | 39+6 (38+1–41+5) |
| Birth weight/kg (mean and range) | 1.16 (0.550–1.635) | 3.550 (2.870–4.670) |
| PMA at image acquisition/weeks (mean and range) | 40 (37+5–42+5) | 42 (39.0–45+3) |
| Weight at image acquisition (mean and range) | 2.890 (2.060–3.920) | 3.628 (2.870–4.500) |
| Orbitofrontal head circumference at image acquisition (mean and range) | 34.7 (31.0–38.0) | 36.1 (32.6–39.0) |
| Gender/M:F | 41:38 | 10:12 |
| Complete course of antenatal steroids | 57 (72%) | 0 |
| Antenatal MgSO4 for fetal neuroprotection | 40 (51%) | 0 |
| Bronchopulmonary dysplasia | 22 (28%) | n/a |
Indicates a statistically significant difference between groups (p ≤ 0.01).
Defined as first dose dexamethasone >24 h before birth.
Defined as need for supplemental oxygen and/or respiratory support at 36 weeks' PMA.
Mean (SD) for tract-averaged mean diffusivity (〈D〉) and fractional anisotropy (FA) for eight tracts-of-interest.
| Acceptable tracts | Mean diffusivity〈D〉(×10−3 mm2/s) | FA | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Preterm ( | Control ( | Preterm | Control | Unadjusted | Adjusted | Preterm | Control | Unadjusted | Adjusted | |
| Genu | 74 | 22 | 0.21 (0.04) | 0.25 (0.04) | <0.001 | 0.428 | ||||
| Splenium | 68 | 22 | ||||||||
| Left CCG | 71 | 18 | 1.372 (0.095) | 1.298 (0.044) | 0.002 | 0.115 | 0.20 (0.03) | 0.23 (0.03) | <0.002 | 0.738 |
| Right CCG | 65 | 18 | 1.350 (0.062) | 1.286 (0.053) | <0.001 | 0.053 | 0.19 (0.03) | 0.20 (0.02) | 0.15 | 0.259 |
| Left CST | 79 | 21 | 1.227 (0.067) | 1.157 (0.062) | <0.001 | 0.292 | 0.29 (0.03) | 0.32 (0.02) | <0.001 | 0.147 |
| Right CST | 79 | 21 | 0.27 (0.03) | 0.30 (0.02) | 0.001 | 0.469 | ||||
| Left ILF | 76 | 19 | ||||||||
| Right ILF | 78 | 21 | 0.22 (0.03) | 0.24 (0.02) | 0.003 | 0.134 | ||||
Adjusted p-values are corrected for postmenstrual age at scan and bold type indicates significant differences in tract-averaged values after adjustment (significance threshold p < 0.05, FDR corrected)
Fig. 1Mean reference tract calculated from the control training data displayed in green and overlaid on the age-specific standard space template. The tracts displayed are genu (a, axial) and splenium (b, axial) of corpus callosum, left CCG (c, sagittal), right CCG (d, sagittal), left CST (e, coronal), right CST (f, coronal), left ILF (g, sagittal), and right ILF (h, sagittal).
Median (IQR/2) values of R for each tract. Significance testing carried out using Mann–Whitney U test. Bold type indicates significant differences in R (p < 0.05, FDR corrected).
| Preterm at term equivalent age | Control | ||
|---|---|---|---|
| Genu | |||
| Splenium | −5.42 (3.16) | −3.08 (4.62) | 0.108 |
| Left CCG | |||
| Right CCG | |||
| Left CST | |||
| Right CST | |||
| Left ILF | |||
| Right ILF | |||
Fig. 2Illustration of the range of absolute goodness-of-fit values (R) observed in the preterm group for genu of the corpus callosum overlaid on FA maps. As values of R become increasingly negative, the deviation of tract topology from reference topology (Fig. 1a) increases.
Fig. 3Scatterplot of tract-averaged FA against tract-averaged 〈D〉 in all segmented tracts for every participant: genu (dark blue); splenium (yellow); CST (red); CCG (green); ILF (purple).